Researchers from four organizations have identified more than 200 new proteins that bind to normal and mutant forms of the protein that causes Huntington’s disease (HD).
The results of the 2006 National Sentinel Audit for Stroke show that patients in Wales are more likely die from stroke, or if they survive will have higher levels of disability than in England or Northern Ireland.
The results of the 2006 National Sentinel Audit for Stroke show that patients are spending more of their time on stroke units, but there are still unacceptable waits for brain scans and starting treatment.
Researchers at the University of Illinois at Chicago explain in the May 11 issue of Circulation Research how an enzyme acts on the heart’s pacemaker to slow the rapid beating of the heart’s “fight-or-flight” reaction to adrenaline.
Scientists from the Center for Applied Medical Research (CIMA) from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.
Researchers at the University of Illinois at Chicago College of Pharmacy have received a $1.7 million five-year federal grant to develop a new approach to treat brain tumors.
The Australian Therapeutic Goods Administration has recalled two ‘herbal’ medicines , Excite for women and Ultimates for men.
Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two, if their current treatment combines the lipid-lowering medication atorvastatin with the blood pressure-lowering medication amlodipine, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Catheter techniques are expanding into new territory, successfully aiding in the replacement of narrowed, calcified aortic valves in patients too sick to withstand open-chest surgery.
Scientists from the Center for Applied Medical Research from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.